FDA Inspection 610032 — Aton Pharma Inc.
The FDA completed an inspection of Aton Pharma Inc. on Sep 10, 2009 in Lawrenceville, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 10, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lawrenceville, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 6730 | 21 CFR 314.80(b) | Failure to develop written procedures |
| 6823 | 21 CFR 314.80(c) | Failure by applicant to report ADE |
| 6832 | 21 CFR 314.80(c)(2) | Late submission of annual safety reports |